MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, AVTX made $59K in revenue. -$78,191K in net income. Net profit margin of -132527.12%.

Income Overview

Revenue
$59K
Net Income
-$78,191K
Net Profit Margin
-132527.12%
EPS
-$5.84
Unit: Thousand (K) dollars
Revenue Breakdown
    • Revenue From Contract With Custo...

Income Statement
2025-12-31
Total revenues, net
59
Cost of product sales
0
Research and development
50,084
Acquired in-process research and development
0
General and administrative
22,900
Total operating expenses
72,984
Loss from operations
-72,925
Change in fair value of derivative liability
-9,520
Interest income, net
4,351
Excess of initial warrant fair value over private placement proceeds
0
Change in fair value of warrant liability
0
Private placement transaction costs
0
Total other (expense) income, net
-5,169
Loss before income taxes
-78,094
Income tax expense
165
Net loss
-78,259
Unrealized income on investments, net
68
Comprehensive loss
-78,191
Basic EPS
-5.84
Diluted EPS
-5.84
Basic Average Shares
13,404,830
Diluted Average Shares
13,404,830
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Comprehensive loss-$78,191K Unrealized income oninvestments, net$68K Net loss-$78,259K Loss before incometaxes-$78,094K Income tax expense$165K Revenue From ContractWith Customer...$59K Loss from operations-$72,925K Total other (expense)income, net-$5,169K Total revenues, net$59K Interest income, net$4,351K Total operatingexpenses$72,984K Change in fair value ofderivative liability-$9,520K Research and development$50,084K General andadministrative$22,900K

Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics, Inc. (AVTX)